Edition:
United States

People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

2.06AUD
26 May 2017
Change (% chg)

$-0.09 (-4.19%)
Prev Close
$2.15
Open
$2.15
Day's High
$2.21
Day's Low
$2.05
Volume
974,160
Avg. Vol
837,797
52-wk High
$3.44
52-wk Low
$1.01

Itescu, Silviu 

Dr. Silviu Itescu is an Chief Executive Officer, Executive Director of Mesoblast Ltd. Prior to founding Mesoblast in 2004, he established an international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure. Dr. Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia. In 2013, Dr. Itescu received the inaugural Key Innovator Award from the Vatican’s Pontifical Council for Culture for his leadership in translational science and clinical medicine in relation to adult stem cell therapy. In 2011, he was named BioSpectrum Asia Person of the Year. Dr. Itescu has consulted for various international pharmaceutical companies, has been an adviser to biotechnology and health care investor groups, and has served on the Board of Directors of several publicly listed life sciences companies.

Basic Compensation

Total Annual Compensation, AUD 1,010,000
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 124,882
Fiscal Year Total, AUD 1,134,880

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --